Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transition Therapeutics Inc (NASDAQ:TTHI)

2.15
Delayed Data
As of 3:59pm ET
 +0.0008 / +0.04%
Today’s Change
1.77
Today|||52-Week Range
9.30
-68.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues29.6M0.0017.9M0.00
 
 
 
Depreciation And Amortization2.1M1.8M1.8M884.9K
 
 
 
 
 
 
Operating ExpensesGross Income---1.8M---884.9K
 
 
 
General Expenses14.4M10.7M10.6M20.0M
 
 
 
 
 
Research And Development8.0M6.4M7.0M15.6M
 
 
 
 
 
Total Operating Expenses16.5M12.6M12.4M20.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income13.1M-12.6M5.5M-20.9M
 
 
 
 
 
Extraordinary Credit0.000.000.002.7M
 
 
Extraordinary Charge--0.00-6.5M-2.9M
 
 
 
Other Expenses-452.2K170.4K905.8K258.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income12.9M-12.2M23.2K-20.6M
 
 
 
 
 
Income Taxes0.000.000.00-230.4K
 
 
Net Income12.9M-12.2M23.2K-20.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.1M25.4M26.8M30.1M
 
 
 
 
 
Shares To Calculate EPS Diluted23.1M25.4M26.8M30.1M
 
 
 
 
 
 
Earnings Per ShareEPS$0.56-$0.48$0.00-$0.67
 
 
 
 
EPS Diluted$0.56-$0.48$0.00-$0.67